Cargando…
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
BACKGROUND: High-dose (HD) tigecycline regimen is increasingly used in infectious diseases, however its efficacy and safety versus low-dose (LD) is still unclear. METHODS: A systematic review and meta-analysis was performed; PubMed, Embase, Cochrane Library, ScienceDirect, Web of Science, clinicalTr...
Autores principales: | Gong, Jinhong, Su, Dan, Shang, Jingjing, Yu, Hai, Du, Guantao, Lin, Ying, Sun, Zhiqiang, Liu, Guangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756684/ https://www.ncbi.nlm.nih.gov/pubmed/31567945 http://dx.doi.org/10.1097/MD.0000000000017091 |
Ejemplares similares
-
Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020) -
Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature
por: Fan, Qiaomei, et al.
Publicado: (2020) -
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016) -
High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
por: Geng, Ting-Ting, et al.
Publicado: (2018) -
Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinolone: A case report
por: Yuan, Xin, et al.
Publicado: (2020)